Politico | India Plays Foul, Cries Corporate America Forbes The Indian Patent Office order granting a compulsory license to Natco stated that 23,120 kidney- and liver-cancer patients would benefit from treatment using Nexavar. In Delhi, a bottle of Sorefenat containing 120 tablets reportedly costs about 8,100 ... Drug companies seek to deliver patents message to Indian prime minister |
